Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price traded up 1% on Friday . The company traded as high as $3.88 and last traded at $3.88. Approximately 709,358 shares changed hands during trading, an increase of 304% from the average daily volume of 175,661 shares. The stock had previously closed at $3.84.
Ono Pharmaceutical Trading Up 1.0 %
The business has a 50-day simple moving average of $4.34 and a 200 day simple moving average of $4.60.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Read More
- Five stocks we like better than Ono Pharmaceutical
- What Are Dividend Champions? How to Invest in the Champions
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 REITs to Buy and Hold for the Long Term
- Top-Performing Non-Leveraged ETFs This Year
- Investing in Commodities: What Are They? How to Invest in Them
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
